Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging

Malignant tumors display remarkable heterogeneity to the extent that even at the same tissue site different types of cells with varying genetic background may be found. In contrast, a relatively consistent marker the scavenger receptor type B1 (SR-B1) has been found to be consistently overexpressed...

Descripción completa

Detalles Bibliográficos
Autores principales: Mooberry, Linda K., Sabnis, Nirupama A., Panchoo, Marlyn, Nagarajan, Bhavani, Lacko, Andras G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156841/
https://www.ncbi.nlm.nih.gov/pubmed/28018216
http://dx.doi.org/10.3389/fphar.2016.00466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156841/
https://www.ncbi.nlm.nih.gov/pubmed/28018216
http://dx.doi.org/10.3389/fphar.2016.00466

Ejemplares similares